Welcome to our dedicated page for Ibex SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IBEX Limited (IBEX) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. As a Nasdaq-listed Bermuda company and emerging growth issuer, IBEX files a range of documents with the U.S. Securities and Exchange Commission that detail its operations, governance, and financial performance.
Key filings include Form 10-K and related annual reports, which present audited financial statements, risk factors, and management’s discussion of results for the fiscal year. Quarterly results and updates are frequently communicated through Form 8-K, where ibex furnishes press releases covering revenue, net income, adjusted net income, adjusted EBITDA, and earnings per share, as well as guidance ranges for future periods.
Investors can also review proxy materials such as the DEF 14A, which describe the board structure, director independence, committee composition, executive compensation programs, long-term incentive plans, and changes in status such as the transition away from controlled company exemptions. Other 8-K filings address governance developments, including the formation of a formal Nominating Committee and related board decisions.
Stock Titan enhances these filings with AI-powered summaries and explanations that highlight important sections, clarify technical language, and surface items that may matter to shareholders, such as governance changes, compensation plans, or capital allocation decisions. Real-time updates from EDGAR ensure that new IBEX filings, including Forms 3, 4, and 5 for insider transactions when available, appear promptly.
Use this page to explore IBEX’s historical and current SEC record, understand how management presents its strategy and performance, and quickly grasp the implications of lengthy documents through AI-generated insights.
IBEX Ltd. insider sale reported: Paul Joseph Inson, listed as Chief People Officer, reported a sale of 3,831 common shares on 09/12/2025 at a price of $38.94 per share. Following the sale, the filing shows Mr. Inson beneficially owns 3,266 shares. The Form 4 was signed by an attorney-in-fact on 09/15/2025. The document contains no additional explanation of the reason for the sale or any derivative transactions.
Paul Joseph Inson, Chief People Officer of IBEX Ltd (IBEX), reported a sale of shares to satisfy tax-withholding obligations related to vested restricted stock units. The Form 4 shows a sale of 255 common shares on 08/26/2025 at a price of $29.13 per share. After the sale, the reporting person beneficially owns 7,097 shares in a direct ownership form. The filing states the sale was executed to cover tax withholding and not as a discretionary trade by the reporting person. The form was filed individually and was signed by an attorney-in-fact on 09/15/2025.
IBEX Ltd reporting person Julie K. Casteel sold 295 common shares at $29.13 per share on 08/26/2025 to cover tax withholding on vested restricted stock units. After the sale the reporting person beneficially owned 30,895 shares, held directly. The Form 4 indicates the sales were required to satisfy tax obligations and were not discretionary trades, signaling they were routine administrative transactions related to equity compensation rather than a change in investment view.
IBEX Ltd insider Christina Alice Trofimuk-O'Connor, identified as the company's Chief Legal Officer and a director, reported a sale of 366 common shares on 08/26/2025 at $29.13 per share. After the transaction she beneficially owned 12,571 shares directly. The filing states the sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. All details above are taken directly from the submitted Form 4.
David Martin Afdahl, Chief Operating Officer of IBEX Ltd (IBEX), reported a non-discretionary sale of 403 common shares on 08/26/2025 at $29.13 per share. The filing states the sale was required to cover tax withholding arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 54,986 common shares directly. The Form 4 was filed as a single-person filing and is signed by an attorney-in-fact.
Bruce Neil Dawson, a director and the company's Chief Sales and CS Officer, reported a sale of 350 common shares of IBEX Ltd on 08/26/2025 at an average price of $29.13 per share. The sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units and is described as required, not a discretionary trade. After the transaction the reporting person beneficially owned 5,257 shares. The Form 4 was filed as an individual report and signed by an attorney-in-fact.
IBEX Limited reported revenue of $558.3 million for the fiscal year ended June 30, 2025, a 9.8% increase over the prior year, and net income of $36.9 million, up 9.5% from $33.7 million. The company attributed growth to new client wins, expansion in offshore and nearshore capacity, and revenue gains in Retail & E-commerce, HealthTech, Travel, Transportation & Logistics, while FinTech and Telecommunications declined. Fully diluted EPS rose to $2.36 from $1.84, helped by higher net income and fewer diluted shares outstanding.
IBEX operates a global delivery model with 30 centers and approximately 33,000 employees as of June 30, 2025, derives 96% of revenue from U.S. customers, and notes concentration risk with its top three clients representing 26% of revenue and the top client about 11%. Management emphasizes a technology-led strategy built around the Wave iX platform and AI initiatives, while disclosing material risks including client concentration, seasonality, cybersecurity, regulatory and tax considerations, debt covenants, and dependence on third-party telecom and internet channels.
IBEX Ltd director and Chief People Officer Paul Joseph Inson reported a sale of 10,000 common shares on 08/22/2025. The shares were sold in multiple trades at prices ranging from $30.00 to $30.13, with a weighted average sale price reported as $30.0013. After the sale, the reporting person beneficially owned 7,352 shares directly. The filing also indicates the transaction was made pursuant to a prearranged plan intended to satisfy Rule 10b5-1(c), and the filer offers to provide trade-by-trade pricing details upon request.
IBEX Limited reported a proposed sale of 10,000 common shares through RBC Capital Markets with an approximate aggregate market value of $300,013. The filing states the shares represent stock grants acquired on 04/20/2022 from the issuer and that the sale is expected on 08/22/2025 on NASDAQ. The filing shows 13,372,404 shares outstanding, and no other sales by the reporting person in the past three months are reported. The filer also affirms they are not aware of any undisclosed material adverse information and notes the legal warning about intentional misstatements.
FAQ
What is the current stock price of Ibex (IBEX)?
What is the market cap of Ibex (IBEX)?
